KaydedilenlerDerginizi ekleyin

Dergiler / Turkish Journal of Biology / 2020 / Cilt: 44 - Sayı: SI-1

Identification of the nucleotide substitutions in 62 SARS-CoV-2 sequences from Turkey

Ayse Banu DEMİR
Domenico BENVENUTO
Hakan ABACİOGLU
Silvia ANGELETTİ
Massimo CİCCOZZİ
Sayfa
178–184
Yayın Tarihi
2020-06-21
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

When the mutations were evaluated, C3037T, C14408T and A23403G were found to be the most common nucleotide substitutions among the viral isolates in Turkey, which are mostly seen as linked mutations and are part of a haplotype observed high in Europe.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:A previously unknown coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been shown to cause coronavirus disease 2019 (COVID-19) pandemic.
📊
Temel Bulgular & Veri:The first case of COVID-19 in Turkey has been declared in March 11th, 2020 and from there on, more than 150,000 people in the country have been diagnosed with the disease.
💡
Sonuç & Katkı:When the mutations were evaluated, C3037T, C14408T and A23403G were found to be the most common nucleotide substitutions among the viral isolates in Turkey, which are mostly seen as linked mutations and are part of a haplotype observed high in Europe.
🔬Tür:Araştırma Makalesi
📍Kapsam:2019 Verileri
⚙️Değişkenler:SARS-CoV-2 · evolution · mutation

Abstract

A previously unknown coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been shown to cause coronavirus disease 2019 (COVID-19) pandemic. The first case of COVID-19 in Turkey has been declared in March 11th, 2020 and from there on, more than 150,000 people in the country have been diagnosed with the disease. In this study, 62 viral sequences from Turkey, which have been uploaded to GISAID database, were analyzed by means of their nucleotide substitutions in comparison to the reference SARS-CoV-2 genome from Wuhan. Our results indicate that the viral isolates from Turkey harbor some common mutations with the viral strains from Europe, Oceania, North America and Asia. When the mutations were evaluated, C3037T, C14408T and A23403G were found to be the most common nucleotide substitutions among the viral isolates in Turkey, which are mostly seen as linked mutations and are part of a haplotype observed high in Europe.

🔖

Bu Makaleye Atıf Yap

DEMİR, A. B., BENVENUTO, D., ABACİOGLU, H., ANGELETTİ, S., CİCCOZZİ, M. (2020). Identification of the nucleotide substitutions in 62 SARS-CoV-2 sequences from Turkey. Turkish Journal of Biology, Cilt: 44 - Sayı: SI-1, 178–184. https://ajindex.com/articles/204383

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (10)

  1. Bai Y, 2020,
  2. EVOLUTION MOL CHARAC, DOI [10.1101/2020.04.24.058933, DOI 10.1101/2020.04.24.058933, 10.1101/2020.04.24.058933.] Benvenuto D, 2020, J INFECTION, V81, pE24, DOI 10.1016/j.jinf.2020.03.058 Eden JS, 2020, VIRUS EVOL, V6, DOI 10.1093/ve/veaa027 Elbe S, 2017, GLOB CHALL, V1, P33, DOI 10.1002/gch2.1018 Eskier D., 2020,
  3. RDRP MUTATIONS ARE A, DOI [10.1101/2020.05.20.104885, DOI 10.1101/2020.05.20.104885] Forster P, 2020, P NATL ACAD SCI USA, V117, P9241, DOI 10.1073/pnas.2004999117 Goh GKM, 2020,
  4. BIOMOLECULES, V10, DOI 10.3390/biom10020331 Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z Hillen HS, 2020,
  5. NATURE, V584, P154, DOI 10.1038/s41586-020-2368-8 Korber B., 2020,
  6. BIORXIV, DOI 10.1101/2020.04.29.069054 Li JG, 2020, J INFECTION, V81, P322, DOI 10.1016/j.jinf.2020.04.016 Lu J, 2020,
  7. CELL, V181, P997, DOI 10.1016/j.cell.2020.04.023 Ou XY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15562-9 Pachetti M, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02344-6 Raj VS, 2013,
  8. NATURE, V495, P251, DOI 10.1038/nature12005 Rehman SU, 2020,
  9. PATHOGENS, V9, DOI [10.3390/pathogens9030240, 10.19045/bspab.2020.90001] Shu YL, 2017,
  10. EUROSURVEILLANCE, V22, P2, DOI 10.2807/1560-7917.ES.2017.22.13.30494 van Dorp L., EVIDENCE INCREASED T, DOI [10.1101/2020.05.21.108506, DOI 10.1101/2020.05.21.108506] Wang CT, 2020, J MED VIROL, V92, P667, DOI 10.1002/jmv.25762